24 results
DEFA14A
AUPH
Aurinia Pharmaceuticals Inc
4 Jun 24
Additional proxy soliciting materials
5:25pm
trust him. Given Mr. Selce's lack of transparency (discussed further below), combined with charges of unethical and illegal conduct, the Company has
PX14A6G
MKT Capital Ltd.
26 Apr 23
Letter to shareholders
10:20am
reduces pay transparency for Aurinia shareholders. The majority of the equity awards did not include performance conditions and the performance shares were
DEF 14A
mze0 lop45
10 May 21
Definitive proxy
4:06pm
PRE 14A
hquxbav
27 Apr 21
Preliminary proxy
4:32pm
10-K
ne3rhins8ueq4b
24 Feb 21
Annual report
4:09pm
SUPPL
zidfm46sv m8
23 Jul 20
Supplemental materials (foreign)
4:06pm
SUPPL
0rdir5
26 Jun 20
Supplemental materials (foreign)
4:08pm
F-10/A
g0j0m0ro7jyhcqq
17 Jun 20
Registration of securities (Canada) (amended)
4:35pm
F-10
p0r unn118nf
29 May 20
Registration of securities (Canada)
4:07pm
SUPPL
d2z 9h8gzh
10 Dec 19
Supplemental materials (foreign)
4:31pm
SUPPL
plqq6t5h dg4qo
9 Dec 19
Supplemental materials (foreign)
6:35am
SUPPL
gkbys2
13 Sep 19
Supplemental materials (foreign)
5:05pm
SUPPL
7bamilj
30 Nov 18
Supplemental materials (foreign)
5:23pm
F-10/A
903xwr c536
16 Oct 15
Registration of securities (Canada) (amended)
12:00am
6-K
EX-99.5
k6hxquz7htu4
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am
6-K
EX-99.4
g2whfiu2 b8npl8ysxwt
15 Aug 14
Aurinia Reports Second Quarter 2014 Financial Results
12:00am